Serial #79198011
LIVE

Serial Number

79198011

Owner

NanoCarrier Co., Ltd.

Attorney

GABRIELLE S. ROTH

Filing Date

Mar 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79198011 Trademark

Serial Number: 79198011 • Registration: 5471859

Serial #79198011 is a trademark filed by NanoCarrier Co., Ltd. on March 3, 2016. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NanoCarrier Co., Ltd. (17 trademarks)

144-15 Chuo,
Chiba 277-0871 , JP

Entity Type: 03

Trademark Details

Filing Date

March 3, 2016

Registration Date

May 22, 2018

Published for Opposition

March 6, 2018

Cancellation Date

December 6, 2024

Goods & Services

Research and developments of anticancer drugs and anticancer preparations; research and developments in the field of pharmaceutical technologies concerning polymeric micelle; research, testing and analysis services for development of products in the nature of pharmaceutical preparations using polymeric micelle; testing, inspection or research of pharmaceuticals, cosmetics and foodstuffs; development of pharmaceutical products, cosmetic products and foodstuffs; consultancy relating to development of pharmaceutical products, cosmetic products and foodstuffs; providing information related to development of pharmaceutical products, cosmetic products and foodstuffs; research and development in the pharmaceutical fields and chemical fields; testing of products, product development, product research; consultancy in the field of product development; analysis and evaluation of product development

Chemical reagents for medical purposes; anticancer drugs; anticancer preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; polymeric micelle anticancer drugs; polymeric micelle anticancer preparation; polymeric micelle pharmaceutical preparations and compositions for the treatment and prevention of cancer; polymeric micelle pharmaceutical preparations, namely, pharmaceutical preparations in the nature of a drug delivery system comprising polymer aggregates (micelle) for the continuous release of a wide variety of therapeutic agents; anticancer drugs using polymers; anticancer preparations using polymers; pharmaceutical preparations and compositions using polymers for the treatment and prevention of cancer; hair growth tonic, namely, hair growth stimulants, and hair growing agent in the nature of medicinal hair growth preparations; medicinal hair growth preparations; medicated creams for treating dermatological conditions; medicated lotions for treating dermatological conditions; detergents for medical purposes; pharmaceutical preparations using polymers, namely, pharmaceutical preparations using polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; deodorizers for household purposes; drug delivery agents consisting of compounds that facilitate delivery of pharmaceutical preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; lacteal flour for babies; beverages for babies; food for babies; dietary supplements for animals; dental materials, namely, dental composite materials, dental alloys, dental polish, dental wax, dental cements, dental resin cement, lining materials for dental purposes, materials for dental fillings and for sealing purposes, bonding and primer materials for dental purposes, dental lacquer, dental adhesives, dental veneers, and fissure sealants for dental purposes; deodorizers for industrial purposes; medicated cosmetics

Skin lotions; milky lotions, namely, face lotions, body lotions, hand lotions, skin cleansing lotions, sun-block lotions, and suntan lotions; beauty serums; cosmetic creams; cosmetics for basic skin care; moisturizing cosmetics for skin; cosmetics for massage, namely, cosmetic massage creams, cosmetic massage oils, cosmetic massage lotions, massage gels, and massage waxes; hair rinses; non-medicated hair treatments preparations; cosmetics for hair care, namely, hair care lotions, hair care creams, hair oils, and hair care preparations; bath salts, other than for medical purposes; bath additives, other than for medical purposes, namely, bath bombs, bath oils, bath melts, bath flakes, bath gels, bath crystals, bath fizzies, bath milk, bath beads, and bath preparations; hair tonics for scalp and hair care; deodorants for human body; cosmetics; facial wash; body soaps; shampoos; soaps, namely, skin soaps, cosmetic soaps, bath soaps, hand soaps, laundry soaps, saddle soaps, and shaving soaps; breath fresheners; deodorants for pets; perfume and ethereal oils; extracts of flowers, namely, perfumes; dentifrices; anti-static preparations for household purposes; degreasing preparations for household purposes; rust removing preparations; fabric softeners for laundry use; laundry bleach; laundry starch; seaweed gelatine for laundry use (Funori)

Chemical reagents for chemical research use; chemical reagents for gene research use, other than for medical and veterinary use; chemical reagents for laboratory use which are used for introducing biological active substance such as molecules and molecular assemblies of peptide and nucleic acids into cells such as prokaryotic cells and eukaryotic cells, other than for medical and veterinary use; chemical reagents, other than for medical and veterinary use; polyethylene glycol-polyamino acid block copolymer, chemicals; polymers, chemicals, namely, unprocessed polymers; chemicals for laboratory use, other than for medical and veterinary use, namely, chemical preparations for analyses and chemical synthesis in laboratories; chemical preparations for use in the manufacture of polymeric micelle preparations in the nature of polymers, amino acids, peptides, lipids and bioactive compounds; chemical preparations for use in the manufacture of medicines; chemicals for use in the manufacture of medicines; humectants; chemical preparations for use in the manufacture of cosmetics; chemicals for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of dietary supplements; chemicals for use in the manufacture of foods; chemical additives for use in manufacture of medicines, cosmetics, and foods; surface-active chemical agents, namely, surfactants for use in the manufacture of medicines, cosmetics and foods; chemical agents for use in industry, namely, emulsifiers for industrial purposes, and surface active compounds for general use in the industrial arts, namely, as wetting, spreading, emulsifying, dispersing and penetrating agents; chemicals for industrial purposes; chemicals for use in science, other than for medical and veterinary use; reagents for medical and pharmaceutical research use

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Feb 12, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 27, 2026 INTS
INVALIDATION PROCESSED
Jan 27, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 6, 2025 INTR
CANCELLED SECTION 71
Dec 6, 2024 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 5, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 5, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 22, 2018 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 1, 2018 OPNX
REGISTERED-PRINCIPAL REGISTER
May 22, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 16, 2018 OPNR
NOTIFICATION PROCESSED BY IB
Mar 9, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2018 NONP
ASSIGNED TO LIE
Jan 26, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 8, 2017 GNFN
FINAL REFUSAL E-MAILED
Aug 8, 2017 GNFR
FINAL REFUSAL WRITTEN
Aug 8, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 11, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 11, 2017 REAP
REFUSAL PROCESSED BY IB
Jan 13, 2017 RFNT
APPLICATION FILING RECEIPT MAILED
Dec 27, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 23, 2016 RFCS
REFUSAL PROCESSED BY MPU
Dec 23, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 22, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 22, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 20, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 15, 2016 REPR